{"id":"https://openalex.org/W1968126540","doi":"https://doi.org/10.1097/00002826-200405000-00011","title":"Acetylcholinesterase and Its Inhibition in Alzheimer Disease","display_name":"Acetylcholinesterase and Its Inhibition in Alzheimer Disease","alternate_titles":[],"publication_year":2004,"publication_date":"2004-05-01","ids":{"openalex":"https://openalex.org/W1968126540","doi":"https://doi.org/10.1097/00002826-200405000-00011","mag":"1968126540","pmid":"https://pubmed.ncbi.nlm.nih.gov/15190239"},"language":"en","primary_location":{"id":"doi:10.1097/00002826-200405000-00011","doi":"https://doi.org/10.1097/00002826-200405000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002826-200405000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1968126540"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112435094","display_name":"Roger M. Lane","orcid":"https://orcid.org/0009-0004-9301-6083","observed_orcids":["https://orcid.org/0009-0004-9301-6083"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Roger M. Lane","raw_affiliation_strings":["Novartis Neuroscience, Novartis Pharmaceuticals Corp., East Hanover, NJ 07936-1080, USA. roger.lane@novartis.com","Novartis Neuroscience, Novartis Pharmaceuticals Corp., East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Neuroscience, Novartis Pharmaceuticals Corp., East Hanover, NJ 07936-1080, USA. roger.lane@novartis.com","institution_ids":[]},{"raw_affiliation_string":"Novartis Neuroscience, Novartis Pharmaceuticals Corp., East Hanover, NJ","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026262571","display_name":"Miia Kivipelto","orcid":"https://orcid.org/0000-0003-0992-3875","observed_orcids":["https://orcid.org/0000-0003-0992-3875"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Miia Kivipelto","raw_affiliation_strings":["Aging Research Center, NEUROTEC, Karolinska Institutet, Stolkholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aging Research Center, NEUROTEC, Karolinska Institutet, Stolkholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056649584","display_name":"Nigel H. Greig","orcid":"https://orcid.org/0000-0002-3032-1468","observed_orcids":["https://orcid.org/0000-0002-3032-1468"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nigel H. Greig","raw_affiliation_strings":["National Institute of Aging, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Aging, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5112435094"],"corresponding_institution_ids":["https://openalex.org/I4210117619"],"apc_list":null,"apc_paid":null,"fwci":0.8928,"has_fulltext":false,"cited_by_count":168,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.6734104,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"27","issue":"3","first_page":"141","last_page":"149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.04280000180006027,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acetylcholinesterase","display_name":"acetylcholinesterase","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cholinergic-hypothesis","display_name":"cholinergic hypothesis","score":0.921999990940094},{"id":"https://openalex.org/keywords/cholinergic-receptors","display_name":"cholinergic receptors","score":0.7049999833106995},{"id":"https://openalex.org/keywords/app-processing","display_name":"APP processing","score":0.8989999890327454},{"id":"https://openalex.org/keywords/tau-phosphorylation","display_name":"tau phosphorylation","score":0.9769999980926514},{"id":"https://openalex.org/keywords/amyloid-beta-aggregation","display_name":"amyloid-beta aggregation","score":0.9909999966621399},{"id":"https://openalex.org/keywords/regional-cerebral-blood-flow","display_name":"regional cerebral blood flow","score":0.8259999752044678},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cholinergic-transmission","display_name":"cholinergic neurotransmission","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.9157469868659973},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.8963323831558228},{"id":"https://openalex.org/C2775910092","wikidata":"https://www.wikidata.org/wiki/Q180623","display_name":"Acetylcholine","level":2,"score":0.6107416749000549},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.5967133641242981},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.554533839225769},{"id":"https://openalex.org/C104966671","wikidata":"https://www.wikidata.org/wiki/Q12167532","display_name":"Cholinergic neuron","level":3,"score":0.5483803749084473},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4769405424594879},{"id":"https://openalex.org/C2779059548","wikidata":"https://www.wikidata.org/wiki/Q383701","display_name":"Ach\u00e9","level":4,"score":0.43455690145492554},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.4200526177883148},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.40529772639274597},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38516101241111755},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3338015377521515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3175157606601715},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24243450164794922},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.21197956800460815},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.16317713260650635},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14483517408370972}],"mesh":[{"descriptor_ui":"D000110","descriptor_name":"Acetylcholinesterase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000110","descriptor_name":"Acetylcholinesterase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000110","descriptor_name":"Acetylcholinesterase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002826-200405000-00011","doi":"https://doi.org/10.1097/00002826-200405000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002826-200405000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:15190239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15190239","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":91,"referenced_works":["https://openalex.org/W3987637","https://openalex.org/W13712814","https://openalex.org/W94310332","https://openalex.org/W163864813","https://openalex.org/W170237590","https://openalex.org/W961590786","https://openalex.org/W1472735294","https://openalex.org/W1504484521","https://openalex.org/W1505503094","https://openalex.org/W1538459592","https://openalex.org/W1562398969","https://openalex.org/W1599716179","https://openalex.org/W1660120640","https://openalex.org/W1707468148","https://openalex.org/W1897469256","https://openalex.org/W1954300187","https://openalex.org/W1977498406","https://openalex.org/W1985980612","https://openalex.org/W1986168671","https://openalex.org/W1986891762","https://openalex.org/W1988940766","https://openalex.org/W1990343815","https://openalex.org/W1993672505","https://openalex.org/W1994956840","https://openalex.org/W1995172525","https://openalex.org/W1997886955","https://openalex.org/W2002969470","https://openalex.org/W2003633347","https://openalex.org/W2003672912","https://openalex.org/W2005259934","https://openalex.org/W2006131134","https://openalex.org/W2007768362","https://openalex.org/W2008538779","https://openalex.org/W2009666036","https://openalex.org/W2010666191","https://openalex.org/W2010730528","https://openalex.org/W2011000826","https://openalex.org/W2014636345","https://openalex.org/W2015629233","https://openalex.org/W2015670774","https://openalex.org/W2018762943","https://openalex.org/W2020710590","https://openalex.org/W2024623973","https://openalex.org/W2025022665","https://openalex.org/W2028378378","https://openalex.org/W2032359251","https://openalex.org/W2034706078","https://openalex.org/W2039089562","https://openalex.org/W2039595489","https://openalex.org/W2043238236","https://openalex.org/W2044329450","https://openalex.org/W2047095305","https://openalex.org/W2048975846","https://openalex.org/W2051679721","https://openalex.org/W2052606088","https://openalex.org/W2054662854","https://openalex.org/W2054792850","https://openalex.org/W2058879779","https://openalex.org/W2064649894","https://openalex.org/W2065719934","https://openalex.org/W2066294875","https://openalex.org/W2066408828","https://openalex.org/W2070883565","https://openalex.org/W2071733462","https://openalex.org/W2072424636","https://openalex.org/W2073594725","https://openalex.org/W2073900106","https://openalex.org/W2074290401","https://openalex.org/W2074576411","https://openalex.org/W2076659819","https://openalex.org/W2076676029","https://openalex.org/W2084107396","https://openalex.org/W2085958374","https://openalex.org/W2090663532","https://openalex.org/W2094181196","https://openalex.org/W2094769478","https://openalex.org/W2100271408","https://openalex.org/W2117164994","https://openalex.org/W2122172872","https://openalex.org/W2125525665","https://openalex.org/W2130992306","https://openalex.org/W2137824309","https://openalex.org/W2145997090","https://openalex.org/W2148069328","https://openalex.org/W2158386063","https://openalex.org/W2163467562","https://openalex.org/W2186469495","https://openalex.org/W2230115146","https://openalex.org/W2418536964","https://openalex.org/W2496331691","https://openalex.org/W3022128479"],"related_works":["https://openalex.org/W1966053837","https://openalex.org/W1976042714","https://openalex.org/W2072219894","https://openalex.org/W2501158478","https://openalex.org/W1976231190","https://openalex.org/W2168978563","https://openalex.org/W4246219565","https://openalex.org/W2904170142","https://openalex.org/W1998822036","https://openalex.org/W2157016321"],"abstract_inverted_index":{"Until":[0],"recently,":[1],"the":[2,10,16,44,77,82,90,100,111,126,156,177,211,219],"only":[3],"established":[4],"function":[5],"of":[6,12,18,79,84,102,128,147,159,210,215,222],"acetylcholinesterase":[7],"(AChE)":[8],"was":[9],"termination":[11],"cholinergic":[13,26,45,63,94,114,129],"neurotransmission.":[14],"Therefore,":[15],"use":[17],"AChE":[19,42,80,137,148,174],"inhibitors":[20,161],"to":[21,121,152,163,172,191,202],"treat":[22],"symptoms":[23],"caused":[24],"by":[25],"imbalances":[27],"in":[28,51,81,99,116,136,218],"Alzheimer":[29],"disease":[30],"(AD)":[31],"represented":[32],"a":[33],"rational":[34],"approach.":[35],"However,":[36],"it":[37],"is":[38,119],"now":[39],"clear":[40],"that":[41,65,118],"and":[43,72,76,92,124,154,166,213],"system":[46],"may":[47,56,109,139,207],"have":[48,96,192,203],"broader":[49],"effects":[50],"AD.":[52,223],"Of":[53],"particular":[54],"interest":[55],"be":[57,164],"signal":[58],"transduction":[59],"pathways":[60],"mediated":[61],"through":[62],"receptors":[64],"promote":[66],"nonamyloidogenic":[67],"amyloid":[68],"precursor":[69],"protein":[70],"processing":[71],"decrease":[73],"tau":[74],"phosphorylation,":[75],"role":[78],"aggregation":[83],"beta-amyloid":[85],"(Abeta)":[86],"peptide.":[87],"In":[88],"addition,":[89],"neuronal":[91],"nonneuronal":[93],"systems":[95],"important":[97],"roles":[98],"modulation":[101],"regional":[103],"cerebral":[104],"blood":[105],"flow.":[106],"These":[107],"findings":[108],"modify":[110],"overly":[112],"simplistic":[113],"hypothesis":[115],"AD":[117],"limited":[120,165],"symptomatic":[122],"treatment":[123],"ignores":[125],"potential":[127],"therapies":[130],"as":[131],"disease-modifying":[132],"agents.":[133],"Chronic":[134],"increases":[135],"activity":[138,175],"exacerbate":[140],"neurodegenerative":[141],"processes,":[142],"make":[143],"clinically":[144],"relevant":[145],"levels":[146],"inhibition":[149],"more":[150],"difficult":[151],"achieve,":[153],"cause":[155],"therapeutic":[157],"value":[158],"cholinesterase":[160],"(ChE-Is)":[162],"temporary.":[167],"Rapidly":[168],"reversible":[169,186],"ChE-Is":[170,187,199],"appear":[171],"increase":[173],"over":[176],"longer":[178],"term":[179],"whereas,":[180],"remarkably,":[181],"irreversible":[182],"or":[183],"very":[184],"slowly":[185],"do":[188],"not":[189],"seem":[190],"this":[193,206],"effect.":[194],"If":[195],"such":[196],"differences":[197],"between":[198],"are":[200],"shown":[201],"clinical":[204],"correlates,":[205],"prompt":[208],"reconsideration":[209],"rationale":[212],"expectations":[214],"some":[216],"agents":[217],"long-term":[220],"management":[221]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1968126540","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
